Literature DB >> 7500107

Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.

E Legius1, M J Descheemaeker, J Steyaert, A Spaepen, R Vlietinck, P Casaer, P Demaerel, J P Fryns.   

Abstract

In a group of 28 children with neurofibromatosis type 1 aged between 4 and 16 years, neuroradiological findings were correlated with intelligence as measured by the Wechsler scales. The presence or specific location in the brain of T2 weighted prolonged signals on MRI was not associated with cognitive problems. No other physical characteristics associated with neurofibromatosis type 1 were found to correlate significantly with IQ. At the present these T2 weighted hyper-intense spots should not be used to predict neurofibromatosis type 1 associated cognitive problems.

Entities:  

Mesh：

Year:  1995        PMID： 7500107      PMCID： PMC1073764          DOI： 10.1136/jnnp.59.6.638

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  14 in total

1.  Neurofibromatosis: implications for learning and behavior.

Authors:  M J Eliason
Journal:  J Dev Behav Pediatr       Date:  1986-06       Impact factor: 2.225

2.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

3.  Learning problems in neurofibromatosis patients.

Authors:  S B Stine; W V Adams
Journal:  Clin Orthop Relat Res       Date:  1989-08       Impact factor: 4.176

4.  Neurofibromatosis in childhood: neuropsychological aspects.

Authors:  M Wadsby; H Lindehammar; O Eeg-Olofsson
Journal:  Neurofibromatosis       Date:  1989

5.  Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis.

Authors:  D W Dunn; K L Roos
Journal:  Neurofibromatosis       Date:  1989

6.  Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children.

Authors:  E Legius; M J Descheemaeker; A Spaepen; P Casaer; J P Fryns
Journal:  Genet Couns       Date:  1994

7.  Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.

Authors:  K North; P Joy; D Yuille; N Cocks; E Mobbs; P Hutchins; K McHugh; M de Silva
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

8.  The significance of MRI abnormalities in children with neurofibromatosis.

Authors:  P K Duffner; M E Cohen; F G Seidel; D W Shucard
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

9.  Neurofibromatosis and psychological processes.

Authors:  C K Varnhagen; S Lewin; J P Das; P Bowen; K Ma; M Klimek
Journal:  J Dev Behav Pediatr       Date:  1988-10       Impact factor: 2.225

10.  Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.

Authors:  T Itoh; S Magnaldi; R M White; M B Denckla; K Hofman; S Naidu; R N Bryan
Journal:  AJNR Am J Neuroradiol       Date:  1994-09       Impact factor: 3.825
View more
  8 in total

1.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

Review 2.  Neurocognitive dysfunction in children with neurofibromatosis type 1.

Authors:  Tena L Rosser; Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

3.  A rational approach to the child with mental retardation for the paediatrician.

Authors:  Jean-François Lemay; Anthony R Herbert; Deborah M Dewey; A Micheil Innes
Journal:  Paediatr Child Health       Date:  2003-07       Impact factor: 2.253

Review 4.  Pediatric brain MRI in neurofibromatosis type I.

Authors:  Hans-J Mentzel; Jörg Seidel; Clemens Fitzek; Annegret Eichhorn; Susanna Vogt; Jürgen R Reichenbach; Felix Zintl; Werner A Kaiser
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

5.  Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.

Authors:  Lianne C Krab; Arja de Goede-Bolder; Femke K Aarsen; Saskia M F Pluijm; Marlies J Bouman; Jos N van der Geest; Maarten Lequin; Coriene E Catsman; Willem Frans M Arts; Steven A Kushner; Alcino J Silva; Chris I de Zeeuw; Henriëtte A Moll; Ype Elgersma
Journal:  JAMA       Date:  2008-07-16       Impact factor: 56.272

6.  Cognitive and psychosocial phenotype of young children with neurofibromatosis-1.

Authors:  Bonita P Klein-Tasman; Kelly M Janke; Wen Luo; Christy L Casnar; Scott J Hunter; James Tonsgard; Pamela Trapane; Faye van der Fluit; Lorri A Kais
Journal:  J Int Neuropsychol Soc       Date:  2013-11-15       Impact factor: 2.892

7.  The Noonan Syndrome-linked Raf1L613V mutation drives increased glial number in the mouse cortex and enhanced learning.

Authors:  Michael C Holter; Lauren T Hewitt; Stephanie V Koebele; Jessica M Judd; Lei Xing; Heather A Bimonte-Nelson; Cheryl D Conrad; Toshiyuki Araki; Benjamin G Neel; William D Snider; Jason M Newbern
Journal:  PLoS Genet       Date:  2019-04-24       Impact factor: 5.917

8.  Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1.

Authors:  Myrthe J Ottenhoff; André B Rietman; Sabine E Mous; Ellen Plasschaert; Daniela Gawehns; Hilde Brems; Rianne Oostenbrink; Rick van Minkelen; Mark Nellist; Elizabeth Schorry; Eric Legius; Henriette A Moll; Ype Elgersma
Journal:  Genet Med       Date:  2020-02-04       Impact factor: 8.822
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.